Becton, Dickinson and Co. (BDX) is a publicly traded Healthcare sector company. As of July 5, 2026, BDX trades at $158.08 with a market cap of $43.56B and a P/E ratio of 40.02. BDX moved +3.39% today. Year to date, BDX is -19.20%; over the trailing twelve months it is -10.83%. Its 52-week range spans $140.11 to $251.99. Analyst consensus is buy with an average price target of $177.00. Rallies surfaces BDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks BDX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $158.08 |
| Market Cap | $43.56B |
| P/E Ratio | 40.02 |
| EPS | $3.95 |
| Dividend Yield | 1.05% |
| 52-Week High | $251.99 |
| 52-Week Low | $140.11 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $21.37B |
| Net Income | $1.14B |
| Gross Margin | 46.79% |
9 analysts cover BDX: 0 strong buy, 4 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $177.00.